(Q35848844)

10 August 2017

Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65. (English)

1 reference

10 August 2017

1 reference

David C Seldin

1

1 reference

10 August 2017

Jennifer J Anderson

2

1 reference

10 August 2017

Martha Skinner

3

1 reference

10 August 2017

Karim Malek

4

1 reference

10 August 2017

Daniel G Wright

5

1 reference

10 August 2017

Karen Quillen

6

1 reference

10 August 2017

Kathleen Finn

7

1 reference

10 August 2017

Betul Oran

8

1 reference

10 August 2017

Vaishali Sanchorawala

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

22 August 2006

1 reference

10 August 2017

3

1 reference

inferred from page(s)

published in

Blood

1 reference

10 August 2017

108

1 reference

10 August 2017

12

1 reference

10 August 2017

3945-3947

1 reference

Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895463

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895463

Stem cell transplantation for the management of primary systemic amyloidosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895463

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895463

Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895463

Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895463

Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895463

Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years

24 September 2018

1 reference

12 December 2020

High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

1 reference

12 December 2020

Outcome of autologous stem cell transplantation for AL amyloidosis in the UK

1 reference

12 December 2020

Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma

1 reference

12 December 2020

Age is not a prognostic variable with autotransplants for multiple myeloma

1 reference

12 December 2020

Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients

1 reference

12 December 2020

10.1182/BLOOD-2006-06-029728

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference